Ask AI

2 Cutting-edge Satellite Symposia at ACC 2026

 
Virtual Simulcast
 
In-Person

2 Cutting-edge Satellite Symposia at ACC 2026

Join Decera Clinical Education for 2 high-impact satellite symposia held in conjunction with ACC.26, led by expert faculty, and packed with clinical insights, interactive case discussions, and evidence-based strategies.

From overcoming clinical inertia in cardio–renal–metabolic disease management to advancing ASCVD risk reduction through modern lipid strategies, the symposia deliver practical tools you can immediately apply in your practice.

Attend in person or virtually—seating is limited, so secure your spot now!

 

Dates Saturday, March 28, 2026
Sunday, March 29, 2026

 

Time Varies per Event
Timezone Converter ›

 

Location Hilton New Orleans Riverside
2 Poydras Street
New Orleans, LA 70130
Room: Grand Ballroom C (First Floor)

Event Schedule

Attend in-person or via virtual simulcast.

March

28

2026

5:30 PM - 7:30 PM Central Time (CT)

In-person

6:00 PM - 7:30 PM Central Time (CT)

Virtual

Featured Faculty

Faculty

Ty J. Gluckman, MD, MHA

  • Medical Director, Center for Cardiovascular Analytics, Research, and Data Science (CARDS)
  • Providence Heart Institute
  • Providence Health System
  • Portland, Oregon
Faculty

Stephen J. Greene, MD

  • Co-Director, Duke Heart Failure Medication Titration Clinic
  • Associate Professor of Medicine, Division of Cardiology
  • Duke Clinical Research Institute
  • Duke University School of Medicine
  • Durham, North Carolina
Faculty

Viet Le, DMSc, MPAS, PA-C, FACC, FAHA, HF-Cert

  • Associate Professor of Research, Preventive Cardiology PA
  • Intermountain Advanced Lipid and Cardiovascular Prevention Clinic
  • Intermountain Health
  • Salt Lake City, Utah
Faculty

Erin D. Michos, MD, MHS, FACC, FAHA, FASE, FASPC

  • Professor of Medicine
  • Director of Women’s Cardiovascular Health
  • Associate Director of Preventive Cardiology
  • Core Faculty, Advanced Lipid Clinic
  • Division of Cardiology
  • Johns Hopkins University School of Medicine
  • Baltimore, Maryland
Faculty

Anne Peters, MD

  • Director
  • USC Clinical Diabetes Programs
  • Professor of Clinical Medicine
  • Keck School of Medicine of USC
  • University of Southern California
  • Los Angeles, California
Faculty

Pam R. Taub, MD, FACC, FASPC

  • Step Family Director’s Endowed Chair
  • Director of Preventive Cardiology
  • Director of Step Family Cardiovascular Rehabilitation and Wellness Center
  • Professor of Medicine
  • UC San Diego Health System
  • La Jolla, California

Grooving Through Lipid Management: A New Rhythm in ASCVD Risk Reduction

Target Audience

This educational activity is intended for cardiology physicians, nurse practitioners, and physician associates who care for patients with ASCVD.

Learning Objectives

Upon completion of this activity, participants should be able to:

  • Recognize Lp(a) as an alternative biomarker of ASCVD risk and of residual risk when taking LDL-C into account
  • Plan individualized, guideline-recommended lipid-lowering treatment strategies using nonstatin or combination therapies to improve patient outcomes, as measured by Lp(a)
  • Implement guideline-directed ASCVD care that addresses gaps in patient-centered approaches and avoids clinical inertia.

Shifting Gears in Cardio–Renal–Metabolic Care: Harnessing Evidenced-Based Therapies to Optimize Patient Outcomes

Target Audience

This educational activity is intended for cardiology physicians, nurse practitioners, and physician associates who care for patients with HF and/or CKD (with or without diabetes).

Learning Objectives

Upon completion of this activity, participants should be able to:

  • Identify persistent gaps in the care of patients with cardio-renal-metabolic disease and the clinical impact of delayed intervention
  • Evaluate emerging evidence on the broad benefits of SGLT2 inhibitors in CRM care to inform earlier initiation and sustained use in appropriate patients
  • Evaluate emerging evidence on the broad benefits of SGLT2 inhibitors in CRM care to inform earlier initiation and sustained use in appropriate patients

Hilton New Orleans Riverside

2 Poydras Street
New Orleans, LA 70130

Acknowledgements

This event is not part of ACC.26 and is not sponsored or endorsed by the American College of Cardiology. This event does not qualify for continuing medical education (CME), continuing nursing education (CNE) or continuing education (CE) credit.

Grooving Through Lipid Management: A New Rhythm in ASCVD Risk Reduction
Provided by Clinical Care Options, LLC dba Decera Clinical Education
Supported by an educational grant from Novartis Pharmaceuticals Corporation.

Shifting Gears in Cardio–Renal–Metabolic Care: Harnessing Evidenced-Based Therapies to Optimize Patient Outcomes
Provided by Clinical Care Options, LLC dba Decera Clinical Education
Supported by an independent medical educational grant from Boehringer Ingelheim Pharmaceuticals, Inc. and Eli Lilly and Company.

Mailing Address
Decera Clinical Education
12001 Sunrise Valley Drive
Suite 304
Reston, VA 20191

For customer support please email:
customersupport@deceraclinical.com